One Platform. Many Applications.
BioThera isolates and characterizes plant-derived extracellular vesicles at manufacturing scale. What those vesicles are formulated into is an application question, not a platform one. Below are the areas the platform is built to serve — and how far each one has actually gone.
Characterized material, documented batch by batch.
Material
Characterized EV bulk
Plant-derived extracellular vesicles isolated at manufacturing scale, counted by Nanoparticle Tracking Analysis and characterized against the MISEV2023 marker framework.
Documentation
Batch-specific CoA
Every batch ships with its own Certificate of Analysis: particle concentration, EV marker panel, and contamination screen. MISEV2023 disclosures available on request.
Logistics
Cold-chain delivery
Shipped directly from the BioThera Solutions facility in Ottawa, Ontario, in cold-chain packaging sized to the destination. No distributor handoff.
Where the platform applies — and how far it has gone.
Maturity reflects how far BioThera has taken each area, not what extracellular vesicles are claimed to do in the literature. Areas marked as research directions have no BioThera product and no published timeline.
Skincare & dermocosmetics
Topical formulation of characterized plant-derived EVs for professional skin care. Supplied to verified dermatology and aesthetic medicine clinics in Canada under our Vesera™ brand. Not in general distribution.
Clinical dermatology
An active safety and efficacy study is underway with practicing dermatologist partners. Clinics evaluating the material receive the batch-specific Certificate of Analysis behind every shipment.
Wound & barrier repair
EV cargo classes associated with wound healing appear in our proteomics data and in the plant-EV literature. We have characterization data; we do not yet have outcome data.
Regenerative medicine
The biomanufacturing and characterization requirements of regenerative applications are the ones this platform was engineered against. No BioThera product exists in this space.
Drug delivery
EVs are a phospholipid-bilayer delivery vehicle. Whether ours can carry an exogenous payload at specification is an open question we are equipped to answer.
Vesera™ — our dermocosmetic brand.
Vesera™ is BioThera’s dermocosmetic brand: plant-derived extracellular vesicles from Aloe barbadensis, formulated for professional skin care. It is a Health Canada-notified cosmetic, characterized to MISEV2023 on every batch. Vesera™ is one application of the platform — not the company.
Standards we manufacture to
Health Canada — 화장품 규정(C.R.C., c. 869)
캐나다 소비자 제품 안전법(C.R.C., c. 869) 하의 캐나다 화장품 규정을 완전히 준수합니다. 캐나다 시장 승인.
MISEV2023 — 특성화 준수
국제 세포외 소포 학회(ISEV)가 발표한 세포외 소포 연구를 위한 최소 정보(MISEV2023) 지침 — 전 세계 표준과 완전히 준수합니다.
Leaping Bunny 동물 실험 반대 인증
유효 인증. 생산 또는 공급망의 어떤 단계에서도 동물 실험 없음.
GMP/ISO 준수 제조
더모코스메틱 및 EV 기반 스킨케어 포트폴리오를 확장함에 따라 GMP 및 ISO 준수를 향해 적극적으로 개발 중인 제조 공정.
FDA — FD&C Act / MoCRA 준수
제형은 연방 식품·의약품·화장품법(FD&C Act, 21 U.S.C. § 361) 및 2022년 화장품 규제 현대화법(MoCRA)와 정렬되어 있습니다. 미국 시장 진입은 향후 단계에 계획되어 있으며—시설 등록 및 완전한 MoCRA 준수는 그 시점에 추진할 예정입니다.
가장 먼저 알아보세요.
저희 대기자 명단에 등록하시면 Vesera™ Serum이 출시될 때 알려드리겠습니다. 귀하가 누구인지도 알고 싶습니다 — 올바른 접근 경로를 우선시하는 데 도움이 됩니다.
BioThera supplies cosmetic-grade material today. Vesera™ is a cosmetic under Health Canada Cosmetic Regulations and is not intended to diagnose, treat, cure, or prevent any disease. Application areas marked as research directions are not products, are not offered for sale, and carry no therapeutic claim.
Talk to us about supply or co-development.
Whether you need characterized EV material with documentation behind it, or want to explore an application that is not on this page, start with a conversation.
Contact the team